<DOC>
	<DOCNO>NCT00520169</DOCNO>
	<brief_summary>This open label , single-center study determine absolute bioavailability nasopharyngeal absorption PMI-150 ( intranasal ketamine ) 30 mg healthy adult volunteer .</brief_summary>
	<brief_title>Absolute Bioavailability Nasopharyngeal Absorption Intranasal Ketamine</brief_title>
	<detailed_description>To examine safety ass absolute bioavailability nasopharyngeal absorption PMI-150 30mg .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy adult 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>bioavailability</keyword>
</DOC>